Tel:
Email: info@col6.it
Learn how to recognize themResearch and developmentContact us

Learn how to recognize them

You can learn how to identify these disorders from an early age by recognising typical signs and symptoms or by means of clinical tests that can shed light on the situation.

Read More

Research and development

Internationally renowned researchers are constantly engaged in the study of possible therapies to combat these disorders.

Read More

Contact us

You can contact the group by hitting the Contact us button, or via email or through the social media. There will always be someone available if you need information.

Read More

About us

Welcome to COL6.it! We are a group of patients and parents of children affected by type VI collagen-linked muscular disorders: Bethlem myopathy, Ullrich congenital muscular dystrophy, myosclerosis myopathy. The main objective of COL6.it is to constitute a reference point for these disorders, where the patients themselves and their families may have the opportunity to meet, with a view to sharing the problems and difficulties these disorders entail. The COL6.it group is actively engaged in supporting medical and scientific research, in particular with testimonies and initiatives targeted towards raising awareness in the institutions and pharmaceutical industries of the necessity to finance projects for the discovery of possible therapies to cure type VI collagen-linked myopathies.

From the Blog

Col6.it: with a view to a more extensive, eye-catching and multi-disciplinary profile Summary of the fourth meeting of the col6.it Group, held on 12th November in the Centro Sociale Ricreativo…

Read More →

Together in col6.it, because united we stand, divided we fall!

Summary of the third reunion of the col6.it group of patients, doctors and researchers 18th June 2016 c/o Centro Sociale Ricreativo e Culturale A. Montanari, Via di Saliceto, 3/21, 40128…

Read More →

Third Meeting Collagen VI Group

Third miting collagen six 6 vi group ullrich bethlem

On Saturday 18th, June 2016, the third meeting of the Collagen VI Group was held in the Centro Sociale Ricreativo e Culturale (Recreational and Cultural Social Center) A. Montanari in…

Read More →

Summary of the second reunion of patients and researchers

A multi-faceted approach to collagen VI research. Summary of the second reunion of patients and researchers, held on 1st November 2015 at the Hotel Ramada Encore, Bologna (Italy) This proved…

Read More →

Anaesthesia recommendations for patients suffering from Collagen VI-related myopathy

      Disease name: Collagen VI-related myopathy ICD 10: G71   Synonyms – Spectrum of phenotypes: Mild: Bethlem myopathy/ benign congenital muscular dystrophy Intermediate: Limb-girdle muscular dystrophy; myosclerosis myopathy Severe:…

Read More →

Debiopharm International SA and Solid Biosciences, LLC, announce a collaboration to explore the use of Alisporivir (Debio 025) in muscular dystrophy.

Debiopharm to start pre-clinical animal studies in Duchenne Muscular Dystrophy (DMD) with Solid Biosciences, a DMD-focused biotech company. Lausanne, Switzerland, and Cambridge, USA – September 8, 2015 – Debiopharm International…

Read More →

Muscular Disorders linked to a Type VI Collagen Deficit: Current State of Research

  Report on the assembly of patients and researchers held on 2nd June 2015, in Sasso Marconi (BO), Italia by Prof. Paolo Bonaldo and his team Dietary modulation and Debio…

Read More →